We are live on ! Find out more
RE

RBC Europe Portfolio holdings

AUM $2.08B
1-Year Est. Return 12.2%
This Fund
S&P 500
This Quarter Est. Return
+9.63%
1 Year Est. Return
-12.2%
3 Year Est. Return
+59.81%
5 Year Est. Return
+127.03%
10 Year Est. Return
–
AUM
$901M
AUM Growth
+$49.6M
Cap. Flow
-$11.2M
Cap. Flow %
-1.24%
Top 10 Hldgs %
43.22%
Holding
1,197
New
53
Increased
118
Reduced
160
Closed
63

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$6.62M
2
MSFT icon
Microsoft
MSFT
+$1.51M
3
TMO icon
Thermo Fisher Scientific
TMO
+$1.47M
4
EL icon
Estee Lauder
EL
+$954K
5
T icon
AT&T
T
+$765K

Top Sells

Rank Stock Value
1
MIME
Mimecast Limited
MIME
+$6.1M
2
AMZN icon
Amazon
AMZN
+$2.55M
3
META icon
Meta Platforms (Facebook)
META
+$2.09M
4
SHLM
Schulman (A.) Inc
SHLM
+$1.58M
5
AAPL icon
Apple
AAPL
+$1.41M

Sector Composition

Rank Sector Weight
1 Financials 21.98%
2 Technology 17.84%
3 Consumer Discretionary 17.26%
4 Communication Services 11.39%
5 Healthcare 10.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ELOX
1101
DELISTED
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
– –
0
– –
CRC
1102
DELISTED
California Resources Corporation
CRC
$243 ﹤0.01%
5
– –
GALT icon
1103
Galectin Therapeutics
GALT
$405M
$240 ﹤0.01%
40
– –
APVO icon
1104
Aptevo Therapeutics
APVO
$4.27M
– –
0
– –
SDRL
1105
DELISTED
Seadrill Limited Common Stock
SDRL
$223 ﹤0.01%
9
-2
-18% -$41
BLRX
1106
BioLineRX
BLRX
$11.4M
– –
0
– –
DSKE
1107
DELISTED
Daseke, Inc. Common Stock
DSKE
$209 ﹤0.01%
26
– –
SCPX
1108
DELISTED
Scorpius Holdings, Inc.
SCPX
– –
0
– –
GTE icon
1109
Gran Tierra Energy
GTE
$349M
$115 ﹤0.01%
3
– –
KZIA
1110
Kazia Therapeutics
KZIA
$155M
$102 ﹤0.01%
1
– –
OPTT icon
1111
Ocean Power Technologies
OPTT
$46.2M
$102 ﹤0.01%
7
– –
FAZ
1112
Direxion Daily Financial Bear 3x ETF
FAZ
$88.2M
– –
0
– –
GENE
1113
DELISTED
Genetic Technologies Ltd.
GENE
$87 ﹤0.01%
4
– –
FRO icon
1114
Frontline
FRO
$9.84B
$81 ﹤0.01%
14
– –
FTR
1115
DELISTED
Frontier Communications Corp.
FTR
$78 ﹤0.01%
12
– –
TPST icon
1116
Tempest Therapeutics
TPST
$17.5M
– –
0
– –
GCVRZ
1117
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$69 ﹤0.01%
130
– –
LSTA icon
1118
Lisata Therapeutics
LSTA
$15.2M
$59 ﹤0.01%
1
– –
ADXS
1119
DELISTED
Advaxis Inc
ADXS
$56 ﹤0.01%
4
– –
CRIS icon
1120
Curis
CRIS
$3.61M
– –
0
– –
NNVC icon
1121
NanoViricides
NNVC
$31.7M
$51 ﹤0.01%
7
– –
VIVE
1122
DELISTED
VIVEVE MED INC
VIVE
– –
0
– –
SRL icon
1123
Scully Royalty
SRL
$88.9M
$49 ﹤0.01%
8
– –
GRCE
1124
Grace Therapeutics
GRCE
$44.6M
$39 ﹤0.01%
1
– –
SNOA icon
1125
Sonoma Pharmaceuticals
SNOA
$6.27M
– –
0
– –
43 44
45
46 47

Similar funds

AP
Advisor Partners Walnut Creek, California $1.42B AUM 3.97% 1-Year Est. Return
AWM
Altium Wealth Management Purchase, New York $1.39B AUM 12.44% 1-Year Est. Return
FWM
Frontier Wealth Management Kansas City, Missouri $1.38B AUM 6.3% 1-Year Est. Return
BRWM
B. Riley Wealth Management Memphis, Tennessee $962M AUM 8.45% 1-Year Est. Return
BDWM
Brewin Dolphin Wealth Management Conskleagh, Dublin, Ireland $917M AUM 12.3% 1-Year Est. Return
DHFB
Dixon Hubard Feinour & Brown Roanoke, Virginia $842M AUM 2.74% 1-Year Est. Return
MCM
Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return
TFM
TPI Fund Managers London, United Kingdom $597M AUM 7.13% 1-Year Est. Return

RBC Europe's Q3 2018 Portfolio in Review

As of Q3 2018, RBC Europe held 1,197 positions worth $901M, up 5.8% from $852M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

RBC Europe's Q3 2018 filing shows 53 new, 118 increased, 160 reduced and 63 closed positions. Its largest new stake was Global X Silver Miners ETF NEW: 17,120 shares worth $415K. The largest sale was Mimecast Limited, an estimated $6.1M.

By sector, the portfolio is most concentrated in Financials at 22% of assets, down from 22% a quarter earlier, followed by Technology and Consumer Discretionary.

  • RBC Europe's largest Q3 2018 buy was Global X Silver Miners ETF NEW: 17,120 shares worth $415K.
  • RBC Europe added most to NVIDIA in Q3 2018, an estimated $6.62M increase.
  • RBC Europe's biggest Q3 2018 reduction was Mimecast Limited, cutting an estimated $6.1M.
  • RBC Europe fully exited Schulman (A.) Inc in Q3 2018, selling an estimated $1.58M.
  • RBC Europe's ten largest holdings make up 43% of its $901M portfolio in Q3 2018.
  • RBC Europe opened 53 new positions and closed 63 in Q3 2018.
  • RBC Europe's portfolio value rose 5.8% quarter-over-quarter to $901M.

Based on RBC Europe's 13F filing for Q3 2018, filed 9 Nov 2023.